技术文章

Molecular Mechanisms and Experimental Evaluation of Mitophagy: PINK1–Parkin, Receptor Recognition, and Lysosomal Flux

Mitophagy is a quality-control process that selectively recognizes and removes damaged, dysfunctional, or physiologically designated mitochondria. Its core processes include damage sensing, selective labeling, autophagic membrane sequestration, and lysosomal degradation. The PINK1–Parkin ubiquitin-dependent pathway and the BNIP3-, NIX-, and FUNDC1-mediated receptor-dependent pathways constitute the major recognition mechanisms.

 

Keywords: mitophagy; PINK1; Parkin; BNIP3; NIX; FUNDC1; mitochondrial quality control; autophagic flux

 

1 Definition and Functional Positioning of Mitophagy

1.1 Definition of Mitophagy

(1) Selective Clearance of Damaged Mitochondria

Mitophagy is a form of selective autophagy in which the substrates are primarily damaged, dysfunctional, or physiologically programmed mitochondria requiring removal. After mitochondrial membrane potential decreases, electron transport becomes impaired, oxidative stress develops, or other homeostatic abnormalities occur, mitochondria can establish connections with LC3/GABARAP-positive autophagic membranes through outer-membrane ubiquitin signals or mitophagy receptors. The isolation membrane extends around the target mitochondrion and closes to form a mitophagosome, which subsequently fuses with lysosomes to complete degradation of mitochondrial components.

(2) Physiological Mitochondrial Remodeling

Mitophagy also participates in erythrocyte maturation, hypoxic adaptation, cell differentiation, and metabolic remodeling. These processes do not necessarily require severe mitochondrial injury but instead programmatically adjust mitochondrial quantity and composition, allowing the mitochondrial pool to adapt to specific cellular states.

 

1.2 Functional Positioning in Mitochondrial Quality Control

(1) Damage Repair and Selective Clearance

Mild mitochondrial damage can be compensated for by mechanisms such as protein quality control and mitochondrial fusion. Localized dysfunctional regions can be separated from the healthy mitochondrial network through mitochondrial dynamic remodeling, whereas persistently or irreversibly damaged mitochondria enter selective degradation pathways. Mitochondrial fission can facilitate isolation and clearance of damaged regions in some models, but not all mitophagy strictly depends on DRP1-mediated fission. Mitochondrial fragmentation itself also does not prove that mitophagy has occurred.

(2) Balance Between Clearance and Biogenesis

Insufficient mitophagy can lead to accumulation of abnormal mitochondria accompanied by increased ROS, impaired ATP production, and mtDNA-related stress. Conversely, if mitochondrial clearance persistently exceeds mitochondrial replenishment capacity, total mitochondrial mass and cellular energy supply may decline. Mitophagy and mitochondrial biogenesis therefore jointly maintain mitochondrial quantity and quality homeostasis.

 

1.3 Mitophagy and General Macroautophagy

General macroautophagy can broadly degrade cytoplasmic proteins, organelles, and other cellular components, whereas mitophagy adds a selective recognition step targeting specific mitochondria. PINK1–Parkin establishes selective outer-mitochondrial-membrane ubiquitination, whereas mitochondrial outer-membrane receptors such as BNIP3, NIX, and FUNDC1 can directly connect mitochondria with LC3/GABARAP, thereby preferentially directing selected mitochondria into the autophagic degradation system.

 

Table 1 Major Differences Between Mitophagy and General Macroautophagy

 

Comparison Dimension

Mitophagy

General Macroautophagy

Major substrates

Damaged or specifically designated mitochondria

Cytoplasmic proteins, organelles, and other cytoplasmic components

Core feature

Selective recognition and clearance of target mitochondria

Can mediate nonselective degradation of cytoplasmic components

Major recognition mechanisms

PINK1–Parkin, BNIP3/NIX, FUNDC1, etc.

Core autophagy machinery and different selective receptors

LC3 connection

Ubiquitin–autophagy receptor–LC3 or mitochondrial receptor–LC3

Direct sequestration or connection through corresponding autophagy receptors

Major function

Control of mitochondrial quality and quantity

Nutrient response and cellular-component turnover

Complete endpoint

Target mitochondria enter lysosomes and are degraded

Autophagic substrates enter lysosomes and are degraded

 

2 Molecular Mechanisms of Mitophagy

Mitophagy sequentially involves damage sensing, selective labeling, recruitment of autophagic membranes, mitochondrial sequestration, and lysosomal degradation. Different damage conditions can generate PINK1–Parkin-mediated ubiquitin signals or establish direct connections between mitochondria and autophagic membranes through receptors such as BNIP3, NIX, and FUNDC1.

 

2.1 Mitochondrial Damage Sensing and Dynamic Remodeling

Reduced mitochondrial membrane potential, abnormal electron transport chain function, increased ROS, impaired proteostasis, and mtDNA damage can all alter mitochondrial quality-control status. DRP1 regulates mitochondrial fission with the participation of factors such as MFF and MID49/MID51 and can facilitate separation of locally damaged regions from the mitochondrial network in some stress models. Mitochondrial fission and autophagic clearance are functionally coupled but do not have a fixed sequential dependency. DRP1 activation, mitochondrial shortening, or fragmentation should therefore be evaluated separately from subsequent autophagic delivery and degradation.

 

2.2 PINK1–Parkin Ubiquitin-Dependent Mitophagy

(1) PINK1 Sensing of Abnormal Membrane Potential

When mitochondrial membrane potential is normal, PINK1 enters mitochondria through the mitochondrial protein-import machinery and is processed by mitochondrial processing peptidases, PARL, and related proteases before undergoing rapid turnover. Following mitochondrial depolarization, normal PINK1 import and processing are disrupted, allowing unprocessed PINK1 to stably accumulate on the outer mitochondrial membrane and maintain kinase activity, thereby converting membrane-potential abnormalities into damage signals recognizable by downstream quality-control systems.

(2) Phosphorylated Ubiquitin and Parkin Activation

Outer-membrane PINK1 phosphorylates ubiquitin at Ser65 and promotes conversion of Parkin from an autoinhibited state to an activated state. Activated Parkin is recruited to damaged mitochondria and ubiquitinates multiple outer-membrane proteins, including MFN1, MFN2, and VDAC. Newly generated ubiquitin chains then serve as additional PINK1 substrates, forming a PINK1–phospho-ubiquitin–Parkin signal-amplification loop that converts initial mitochondrial damage into a high-density outer-membrane ubiquitin signal.

(3) OPTN, NDP52, and TBK1

Ubiquitinated mitochondria can recruit selective autophagy receptors such as OPTN and NDP52. These receptors recognize target mitochondria through ubiquitin-binding regions and connect them to LC3/GABARAP through LIR-related structures. TBK1 participates in phosphorylation-dependent regulation of receptors such as OPTN, strengthening the connection between damaged mitochondria and the autophagic system. PINK1–Parkin mainly performs selective labeling and recruitment of autophagy machinery, whereas final mitochondrial degradation still depends on the autophagosome–lysosome system.

 

2.3 Receptor-Dependent Mitophagy

(1) BNIP3

BNIP3 is localized to the outer mitochondrial membrane, and its cytoplasmic LIR domain can bind LC3/GABARAP, thereby establishing a connection between mitochondria and autophagic membranes without requiring Parkin-mediated extensive outer-membrane ubiquitination. BNIP3 mainly participates in selective mitochondrial clearance under hypoxia, metabolic stress, and certain tissue-injury conditions.

(2) NIX/BNIP3L

NIX is structurally related to BNIP3 and similarly connects to LC3/GABARAP through an LIR domain. NIX has an important role in mitochondrial removal during erythrocyte maturation and also participates in mitophagy associated with hypoxia, cell differentiation, and metabolic remodeling. Its LIR activity can be regulated by post-translational modifications.

(3) FUNDC1

FUNDC1 is an outer-mitochondrial-membrane LIR-containing receptor whose interaction with LC3 is regulated by phosphorylation status. Under hypoxic conditions, dephosphorylation of FUNDC1-related sites can enhance its interaction with LC3, allowing target mitochondria to recruit autophagic membranes more effectively and enter the clearance process.

 

2.4 Functional Differences Between Ubiquitin-Dependent and Receptor-Dependent Pathways

The PINK1–Parkin pathway has been extensively studied under conditions of pronounced depolarization and severe mitochondrial injury, whereas BNIP3, NIX, and FUNDC1 are more prominent during hypoxia, differentiation, and specific metabolic adaptations. Basal mitochondrial turnover is not entirely dependent on PINK1/Parkin, and multiple parallel mechanisms of selective mitochondrial clearance can operate under physiological conditions.

 

Table 2 Two Major Mitophagy Recognition Mechanisms

 

Mechanism Type

Major Stimulus

Selective Label

LC3/GABARAP Connection

Representative Molecules

Ubiquitin-dependent

Depolarization, severe mitochondrial damage

PINK1–Parkin-mediated outer-membrane ubiquitination

Indirect connection through OPTN, NDP52, etc.

PINK1, Parkin, OPTN, NDP52, TBK1

Receptor-dependent

Hypoxia, differentiation, metabolic stress

Mitochondrial outer-membrane receptor itself

LIR directly binds LC3/GABARAP

BNIP3, NIX, FUNDC1

 

2.5 Autophagic Membrane Formation and Mitochondrial Sequestration

The ULK1 complex participates in autophagy initiation, the BECN1–VPS34-related complex promotes PI3P generation and isolation-membrane formation, and ATG7, ATG3, and the ATG12–ATG5–ATG16L1 system participate in LC3/GABARAP lipidation. OPTN, NDP52, BNIP3, NIX, or FUNDC1 connects target mitochondria to LC3/GABARAP-positive membrane structures, after which the isolation membrane extends along the mitochondrial surface and closes to form a double-membrane mitophagosome.

 

2.6 Lysosomal Degradation and Mitochondrial Renewal

(1) Mitophagosome Degradation

After mature mitophagosomes fuse with lysosomes, mitochondrial outer membranes, inner membranes, respiratory-chain components, and matrix proteins are degraded in the acidic environment by lysosomal hydrolytic systems. When lysosomal acidification or autophagosome–lysosome fusion is impaired, LC3-II accumulation and increased mitochondria–autophagosome colocalization may occur even though actual mitochondrial degradation flux is reduced.

(2) Mitochondrial Biogenesis and Replenishment

Regulatory networks including PGC-1α, NRF1/NRF2, and TFAM participate in mitochondrial biogenesis and replenishment of mitochondrial components. Complete mitochondrial quality control therefore includes damage sensing, dynamic remodeling, selective labeling, autophagic membrane sequestration, lysosomal degradation, and mitochondrial biogenesis. The balance between clearance rate and replenishment capacity determines mitochondrial homeostasis.

 

3 Establishment of Mitophagy Models

3.1 Depolarization-Induced Models

(1) CCCP and FCCP

CCCP and FCCP dissipate the proton gradient across the inner mitochondrial membrane and reduce membrane potential and are commonly used in PINK1–Parkin-related mitophagy research. PINK1 stabilization, Parkin translocation, and outer-membrane ubiquitination can be detected after treatment. High concentrations or prolonged treatment may cause substantial ATP depletion and cell death, so model conditions should be determined by jointly evaluating membrane potential, ATP, and cell viability.

(2) Valinomycin

Valinomycin alters transmembrane ion gradients and mitochondrial membrane potential through selective K⁺ transport. Its mechanism of membrane-potential disruption differs from protonophores and can therefore be used to compare how different modes of depolarization affect damage recognition and mitochondrial clearance.

 

3.2 Electron Transport Chain Injury Models

(1) Rotenone

Rotenone inhibits mitochondrial electron transport chain complex I, causing respiratory dysfunction, increased ROS, and mitochondrial damage. This model is suitable for mechanistic studies linking complex I dysfunction, oxidative stress, and mitochondrial quality control and has a different injury context from rapid depolarization systems such as CCCP.

(2) Antimycin A and Oligomycin

Antimycin A inhibits electron transport through complex III and promotes ROS generation, whereas oligomycin inhibits F₀F₁-ATP synthase and restricts ATP production. These treatments can respectively establish electron-transport dysfunction and energy-production restriction and can be used to compare the effects of different metabolic injuries on mitophagy initiation and clearance efficiency.

 

3.3 Autophagic Flux Intervention

(1) Bafilomycin A1 and Chloroquine

Bafilomycin A1 interferes with late-stage autophagy by affecting V-ATPase and lysosomal acidification, whereas chloroquine alters lysosomal function and inhibits degradation of autophagic substrates. Comparing LC3, mitochondrial proteins, and mitochondria–lysosome delivery before and after late-stage blockade can help determine mitochondrial degradation flux.

(2) 3-MA and Rapamycin

3-MA is commonly used to interfere with PI3K-related autophagic processes, whereas Rapamycin promotes autophagy through mTOR-related mechanisms. Both can be used to analyze the relationship between mitochondrial clearance and the core autophagy machinery, but neither is a mitophagy-specific tool.

 

3.4 Intervention in Mitochondrial Dynamics

Mdivi-1 is commonly used in studies of mitochondrial dynamics, but its experimental effects should not be simply equated with specific DRP1 inhibition. Mdivi-1 can also affect mitochondrial complex I, respiration, and ROS generation. Related experiments should therefore combine DRP1 status, mitochondrial morphology, respiratory function, and genetic intervention for mechanistic confirmation.

 

Table 3 Common Mitophagy Models and Intervention Methods

 

Model/Intervention

Major Effect

Suitable Research Stage

Major Evaluation Indicators

CCCP/FCCP

Rapid reduction of mitochondrial membrane potential

PINK1–Parkin activation

PINK1, Parkin, p-Ub, membrane potential

Valinomycin

Alters K⁺ gradient and membrane potential

Depolarization-dependent damage recognition

JC-1, PINK1, Parkin

Rotenone

Inhibits complex I

ROS and persistent mitochondrial damage

ROS, membrane potential, ATP, mitochondrial clearance

Antimycin A

Inhibits complex III

ROS and electron-transport damage

ROS, membrane potential, autophagic flux

Oligomycin

Inhibits ATP synthase

Energy-metabolic stress

ATP, AMPK, autophagy-related indicators

Bafilomycin A1/Chloroquine

Interferes with lysosomal degradation

Flux validation

LC3, mitochondrial proteins, lysosomal delivery

Mdivi-1

Affects mitochondrial dynamics and respiration-related processes

Mitochondrial dynamics

DRP1, mitochondrial morphology, respiration, clearance efficiency

 

4 Experimental Evaluation and Flux Analysis of Mitophagy

4.1 Activation of the PINK1–Parkin Pathway

(1) PINK1 and Parkin

Accumulation of PINK1 on the outer mitochondrial membrane reflects damage recognition following depolarization, while translocation of Parkin from the cytoplasm to mitochondria reflects initiation of the downstream ubiquitination program. Western blotting, immunofluorescence, and mitochondrial/cytoplasmic fractionation can all be used for evaluation. Both indicators represent early events in mitophagy and cannot directly demonstrate that mitochondria have completed degradation.

(2) Phosphorylated Ubiquitin and Receptor Recruitment

Ser65-phosphorylated ubiquitin, ubiquitination of outer-mitochondrial-membrane proteins, and OPTN/NDP52–TBK1-related alterations can further evaluate selective labeling and receptor recruitment. Complete mechanistic validation should cover PINK1/Parkin, ubiquitin signaling, autophagy receptors, autophagic membranes, and lysosomal degradation.

 

4.2 LC3, p62, and Mitochondrial Sequestration

Colocalization of LC3 with mitochondrial markers such as TOMM20 and VDAC can reflect spatial association between mitochondria and autophagic membranes, while p62/SQSTM1 can assist in evaluating turnover of ubiquitinated substrates. Increased LC3-II may result from either enhanced autophagosome formation or impaired lysosomal degradation. Mitochondria–LC3 colocalization mainly reflects recruitment or sequestration and cannot independently demonstrate increased complete mitophagic flux.

 

4.3 Mitochondria–Lysosome Delivery

(1) Colocalization of Mitochondria and Lysosomes

Combined detection using mitochondrial fluorescent probes with lysosomal acidic-compartment probes, LAMP1, or LAMP2 can visualize the spatial relationship between mitochondria and lysosomes. Increased colocalization supports mitochondrial delivery to lysosomes, but static colocalization cannot directly distinguish increased delivery from substrate accumulation caused by impaired downstream degradation.

(2) mt-Keima and mito-QC

mt-Keima evaluates mitochondria–lysosome delivery through pH-dependent spectral changes that occur when mitochondria enter acidic compartments. mito-QC uses differences in the stability of GFP and mCherry in acidic environments to identify mitochondria that have entered lysosomes. These reporter systems more directly reflect the key process of mitochondrial entry into acidic degradation compartments.

 

4.4 Mitochondrial Mass and Function

Decreases in mitochondrial proteins such as TOMM20, VDAC, and COX IV can suggest reduced mitochondrial mass but may also result from reduced mitochondrial biogenesis, altered protein expression, or cell death. JC-1, ATP, and ROS are used to evaluate membrane potential, energy production, and oxidative stress, respectively, and can determine whether changes in mitochondrial quantity are accompanied by altered functional status.

 

4.5 Determination of Mitophagic Flux

Further accumulation of mitophagy-related substrates after Bafilomycin A1 or chloroquine treatment supports ongoing lysosomal degradation under the original condition. If substrate accumulation after downstream blockade is limited, pre-existing restriction of the late autophagic stage should be considered. PINK1 accumulation, Parkin translocation, LC3-II elevation, mitochondria–LC3 colocalization, and TOMM20 reduction each reflect different stages and cannot individually replace complete flux evaluation.

 

5 Mitophagy in Disease and Aging

5.1 Neurodegenerative Diseases

Functional abnormalities of PINK1 and PRKN/Parkin are closely associated with hereditary Parkinson’s disease. Neurons are highly dependent on mitochondrial oxidative phosphorylation and have complex requirements for axonal transport and local energy supply. Abnormal mitochondrial quality control can affect ROS homeostasis, energy supply, and neuronal survival. The PINK1–Parkin pathway therefore represents an important mechanistic axis in studies of mitochondrial quality control in neurodegenerative diseases.

 

5.2 Cardiovascular Injury

Cardiomyocytes have high mitochondrial density and continuous energy requirements. Ischemia, reperfusion, and hypoxia can cause abnormalities in membrane potential, redox status, and calcium homeostasis. Moderate mitophagy helps limit accumulation of damaged mitochondria, whereas imbalance between clearance and mitochondrial biogenesis can affect total mitochondrial mass and ATP supply. Related studies should therefore simultaneously evaluate mitochondrial clearance, biogenesis, and energy status.

 

5.3 Aging

During aging, mtDNA damage, oxidative stress, proteostasis abnormalities, and changes in lysosomal function can all reduce mitochondrial renewal efficiency. Insufficient mitophagy can increase the burden of abnormal mitochondria, while enhanced clearance without sufficient biogenesis can likewise reduce mitochondrial reserves. The balance of mitochondrial turnover therefore reflects overall quality-control status more effectively than any single autophagy indicator.

 

6 Products Related to Mitophagy

6.1 Products Related to Model Construction and Pathway Regulation

 

Catalog #

Product Name

Grade & Purity

Mechanism

Research Application

C1509561

CCCP solution (10mmol/L)

BioReagent, 10 mmol/L

Acts as a protonophore to dissipate mitochondrial membrane potential and induce depolarization

PINK1–Parkin-related mitophagy models and membrane-potential controls

C423663

Carbonyl cyanide 4-(trifluoromethoxy)phenylhydrazone

10mM in DMSO

Uncouples oxidative phosphorylation and reduces mitochondrial membrane potential

Mitochondrial depolarization and PINK1–Parkin pathway research

R105077

Rotenone

Analytical standard, ≥96%, Moligand™

Inhibits mitochondrial complex I and induces respiratory dysfunction and oxidative stress

Quantitative analysis of rotenone, methodological controls, and complex I-related analytical studies

A329337

Antimycin A4

Moligand™, ≥98%

Inhibits electron transport through mitochondrial complex III and promotes ROS generation

Electron transport chain injury and mitophagy research

O1498592

Oligomycin A

Moligand™, 10 mM in DMSO

Inhibits mitochondrial F₀F₁-ATP synthase and restricts ATP production

Energy-metabolic stress and mitochondrial quality-control research

V1522931

Valinomycin

≥98%(TLC), ≥93%(HPLC)

Selectively transports K⁺ and alters the mitochondrial transmembrane ion gradient

Mitochondrial membrane-potential disruption and damage-recognition research

M303472

Mdivi-1

≥96%

Can affect the mitochondrial-fission phenotype while also influencing mitochondrial respiration-related processes

Relationship between mitochondrial dynamics and mitophagy

P1425444

PARL-IN-1

 

Interferes with PARL-related PINK1 processing and affects PINK1 stability

PINK1-related mitochondrial quality-control mechanism research

B101389

Bafilomycin A1

≥95%

Interferes with V-ATPase function and lysosomal acidification

Late-stage mitophagy blockade and flux validation

C193834

Chloroquine

Moligand™, ≥97%

Interferes with lysosomal function and degradation of autophagic substrates

Late-stage mitophagy blockade control

M486160

3-Methyladenine

Autophagy inhibitor

Interferes with PI3K-related autophagic processes

Analysis of the contribution of the core autophagy program to mitochondrial clearance

R408790

Rapamycin (AY-22989)

Moligand™, 10mM in DMSO

Inhibits mTOR and promotes autophagy-related programs

mTOR–autophagy and mitochondrial quality-control research

M647144

Mito-LND

≥97%

Targets mitochondrial metabolism and induces mitochondrial stress-related changes

Mitochondrial metabolic injury and autophagy-mechanism research

 

6.2 Products Related to Autophagy, Mitochondrial Dynamics, and Lysosomal Detection

 

Catalog #

Product Name

Grade & Purity

Detection Target/Principle

Research Application

Ab131950

Recombinant TOMM20 Antibody

Recombinant, ExactAb™, Validated, See COA

Detects the outer-mitochondrial-membrane protein TOMM20

Mitochondrial localization, mitochondrial mass, and colocalization analysis

Ab112866

Recombinant LC3B Antibody

Recombinant, ExactAb™, Validated, See COA

Detects LC3B and LC3 lipidation-related changes

Evaluation of autophagic membrane recruitment and autophagosome formation

Ab129090

SQSTM1 Mouse mAb

Carrier Free, ExactAb™, Validated, High Performance, See COA

Detects p62/SQSTM1 and selective-autophagy-substrate-related changes

Evaluation of ubiquitinated-substrate recognition and turnover

Ab089177

Recombinant APG5L/ATG5 Antibody

Recombinant, ExactAb™, Validated, 0.3 mg/mL

Detects ATG5 associated with autophagosome formation

Core autophagy machinery and autophagic membrane elongation research

Ab090924

Recombinant Beclin 1 Antibody

Recombinant, ExactAb™, Validated, See COA

Detects Beclin 1-related autophagy-initiation signaling

Autophagy initiation and isolation-membrane formation mechanism research

Ab187900

LAMP1 Mouse mAb

Carrier Free, ExactAb™, Azide Free, Validated, ≥95%(SDS-PAGE), 1.0 mg/mL

Detects the lysosomal membrane protein LAMP1

Lysosomal localization and mitochondria–lysosome colocalization to support evaluation of terminal mitochondrial delivery to lysosomes

Ab325845

Recombinant LAMP2 Antibody

KD Validation

Detects the lysosomal membrane protein LAMP2

Autophagy–lysosome system and terminal degradation research

Ab326346

Recombinant MFN1 Antibody

KD Validation

Detects the outer-mitochondrial-membrane fusion protein MFN1

Coupling between mitochondrial fusion and mitophagy

EJ1514542

Human Mitofusin 2 (MFN2) ELISA Kit

BioReagent

Quantitatively detects MFN2

MFN2 quantification to support evaluation of mitochondrial fusion-related status

Ab117037

Recombinant TBK1 (phospho S172) Antibody

Recombinant, ExactAb™, Validated, See COA

Detects Ser172-phosphorylated TBK1

TBK1 activation and selective-autophagy receptor regulation research

 

6.3 Products for Evaluation of Mitochondrial Function, Oxidative Stress, and Cellular Status

 

Catalog #

Product Name

Grade & Purity

Detection Principle

Research Application

M1508380

Mitochondrial Membrane Potential Assay Kit (JC-1)

BioReagent, for Fluorescence analysis, Suitable for molecular biology

Evaluates mitochondrial membrane potential according to changes in JC-1 aggregation state

Depolarization models and mitochondrial-function evaluation

R272916

Reactive Oxygen Species Assay Kit

 

Evaluates cellular ROS levels through reactive oxygen species-sensitive signals

Cellular ROS and oxidative-stress evaluation, combined with mitochondria-specific readouts to support assessment of mitochondrial injury

A1527009

ATP Content Assay Kit (NADPH Rate, UV Micro Method)

BioReagent

Evaluates ATP content through an NADPH-related coupled reaction

Evaluation of ATP content and overall cellular energy status, combined with mitochondrial-respiration readouts to support analysis of mitochondrial energy metabolism

M1455293

MitoTracker Orange CMTMRos (Mitochondrial Orange Fluorescent Probe)

BioReagent, Biological Stain, for Fluorescence analysis, for Microscopy, ≥98%

Fluorescently labels mitochondria and reflects their spatial distribution

Mitochondrial localization, morphology, and colocalization analysis

A1456401

Mitochondrion Red Probe (AIE)

BioReagent, for microscopy, Biological Stain, ≥98%(HPLC), 50 mM in DMSO

Fluorescently labels cellular mitochondria

Mitochondrial imaging and mitochondria–lysosome spatial analysis

L747763

Lyso-Tracker Red

 

Accumulates in acidic organelles and generates a fluorescent signal

Lysosomal localization and mitochondria–lysosome colocalization

A1456409

Lysosome Red Probe (Aggregation-Induced Emission, AIE)

BioReagent, for microscopy, Biological Stain, ≥98%(HPLC), 10mM in DMSO

Fluorescently labels cellular lysosomes

Terminal mitophagy delivery and lysosomal imaging

H1434215

HKSOX-1m (5/6-mixture)

 

Mitochondria-targeted fluorescent detection of superoxide anions

Evaluation of mitochondria-derived oxidative stress

A1372286

Annexin V-FITC/PI Apoptosis Detection Kit

Suitable for Immunofluorescence (IF), BioReagent, Biological Stain, for microscopy

Annexin V and PI jointly evaluate apoptosis and plasma-membrane integrity

Exclusion of cell-death interference caused by severe mitochondrial injury

 

Mitophagy removes abnormal mitochondria through damage sensing, selective recognition, autophagic membrane sequestration, and lysosomal degradation. PINK1–Parkin and the BNIP3-, NIX-, and FUNDC1-mediated pathways participate in selective recognition under different stress and physiological conditions. Experimental evaluation requires integrated analysis of upstream signaling, mitochondrial sequestration, lysosomal delivery, degradation flux, and mitochondrial function, together with mitochondrial biogenesis to determine the overall state of mitochondrial quality control.

 

References

[1] Lu Y, et al. Cellular mitophagy: Mechanism, roles in diseases and small molecule pharmacological regulation. Theranostics. 2023;13(2):736-766.

[2] Lemasters JJ. Selective mitochondrial autophagy, or mitophagy, as a targeted defense against oxidative stress, mitochondrial dysfunction, and aging. Rejuvenation Res. 2005;8(1):3-5.

[3] Riley BE, Lougheed JC, Callaway K, et al. Structure and function of Parkin E3 ubiquitin ligase reveals aspects of RING and HECT ligases. Nat Commun. 2013;4:1982.

[4] Lazarou M, Sliter DA, Kane LA, et al. The ubiquitin kinase PINK1 recruits autophagy receptors to induce mitophagy. Nature. 2015;524(7565):309-314.

[5] Vargas JNS, Wang C, Bunker E, et al. Spatiotemporal Control of ULK1 Activation by NDP52 and TBK1 during Selective Autophagy. Mol Cell. 2019;74(2):347-362.e6.

 

For more related articles, please see below:

[1] Experiments on oxidation and phosphorylation in isolated mitochondria

[2] Experiments on live staining of mitochondria in cells

[3] Experiments on the hierarchical separation of mitochondria

[4] Oxidative Stress and Experimental Interpretation Framework for ROS, JC-1, MPTP, and Calcium Indicators in Mitochondrial Function Assessment

[5] Mitochondrial Stress Signaling and Disease

目录: 技术文章

Da — 若无特别说明,分子量单位默认为道尔顿。   Mw — 重均分子量。   Mn — 数均分子量。

产品仅供科研与开发使用,不用于人体、动物、诊断或治疗。

引用本文

阿拉丁科学.《Molecular Mechanisms and Experimental Evaluation of Mitophagy: PINK1–Parkin, Receptor Recognition, and Lysosomal Flux》. 阿拉丁知识库,更新于 2026年9月20日。 https://www.aladdin-e.com/zh_cn/faqs/molecular-mechanisms-and-experimental-evaluation-of-mitophagy-en.html
这篇文章对您有帮助吗? Yes No 有 1 人觉得有帮助